Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Leaders to Discuss AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 202...
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
Dr. Reddy's Laboratories Ltd (RDY)
US:NYSE Investor Relations:
drreddys.com/investors
Company Research
Source: Yahoo! Finance
company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced further details on its in-person R&D day at the Lotte New York Palace Hotel on Tuesday, June 11, 2024, at 10:00 AM ET. To register, click here The R&D day will feature in-depth presentations focused on the Company's lead program, atrioventricular interval modulation (AVIM) therapy, including: The high unmet need for treatment of uncontrolled hypertension in pacemaker-indicated patients and other older high-risk patients The AVIM therapy mechanism of action and supporting clinical and non-clinical mechanistic data The robust existing body of clinical evidence from the MODERATO I and II studies Design of and rationale for the BACKBEAT global pivotal study In addition to Orchestra BioMed management presentations, the event will include esteemed key opinion leading physicians: David Kandzari, M.D., FACC, FSCAI, Chief of the Piedmont Heart Institute and Cardiova
Show less
Read more
Impact Snapshot
Event Time:
RDY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RDY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RDY alerts
High impacting Dr. Reddy's Laboratories Ltd news events
Weekly update
A roundup of the hottest topics
RDY
News
- Active Pharmaceutical Ingredients (APIs) Market Size Expected to Reach USD 344.91 Billion by 2032 [Yahoo! Finance]Yahoo! Finance
- Global Lenalidomide Drug Market Size To Worth USD 21.47 Billion By 2033 | CAGR Of 5.69% [Yahoo! Finance]Yahoo! Finance
- Aurigene Pharmaceutical opens biologics facility in Hyderabad, India [Yahoo! Finance]Yahoo! Finance
- Aurigene Pharmaceutical Services Limited, a Global CRDMO, Announces the Opening of Its Biologics Facility Offering Process Development and Clinical Scale Manufacturing Capabilities [Yahoo! Finance]Yahoo! Finance
- Aurigene Pharmaceutical Services Limited, a Global CRDMO, Announces the Opening of Its Biologics Facility Offering Process Development and Clinical Scale Manufacturing CapabilitiesBusiness Wire
RDY
Earnings
- 5/8/24 - Beat
RDY
Sec Filings
- 6/24/24 - Form 6-K
- 6/21/24 - Form 6-K
- 6/20/24 - Form 6-K
- RDY's page on the SEC website